Positron emission tomography (PET) is a molecular imaging technique that captures functional or phenotypic changes associated with pathology.[1] This research field is currently fuelled by the need for conceptually new 18F-radiolabeling methods to satisfy clinical demand.[2] 18F-labeled aryl derivatives are highly sought after in the context of both drug and radiotracer development because of their advantageous metabolic profile for in ...
